Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co Days Payable Chart
Inner Mongolia Furui Medical Science Co Annual Data
SZSE:300049 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inner Mongolia Furui Medical Science Co Days Payable vs Biotechnology Industry
Inner Mongolia Furui Medical Science Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co (SZSE:300049) has a Days Payable of 131.71 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. This is 41% above median its historical median of 93.28. Over the past decade, Inner Mongolia Furui Medical Science Co's Days Payable has ranged from 79.92 to 111.39. According to the industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #365 out of 704 companies in the Biotechnology industry, placing it in the top 51.8%.
Is Inner Mongolia Furui Medical Science Co's Days Payable too high?
Inner Mongolia Furui Medical Science Co's current Days Payable of 131.71 is 41% above median its 10-year median of 93.28. Over the past 10 years, this metric has ranged from a low of 79.92 to a high of 111.39. The Biotechnology industry median Days Payable is 110.01. Inner Mongolia Furui Medical Science Co's value of 131.71 is 19.7% above this industry median. Based on the distribution chart, Inner Mongolia Furui Medical Science Co ranks #365 out of 704 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Inner Mongolia Furui Medical Science Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Furui Medical Science Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #365 out of 704 companies for Days Payable. This places Inner Mongolia Furui Medical Science Co in the lower half of its industry. The industry median Days Payable is 110.01. Inner Mongolia Furui Medical Science Co's value of 131.71 is 19.7% above this benchmark. Historically, Inner Mongolia Furui Medical Science Co's own Days Payable has ranged from 79.92 to 111.39 over the past decade. While the company's 10-year median is 93.28 vs. the industry median of 110.01, Inner Mongolia Furui Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 110.01, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inner Mongolia Furui Medical Science Co's current Days Payable of 131.71 is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. For the Biotechnology industry, the median Days Payable is 110.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inner Mongolia Furui Medical Science Co's current Days Payable is 131.71, which is 41% above median its own 10-year median of 93.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Furui Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co (SZSE:300049) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥65.97, compared to a current price of ¥43.94 — trading 33.4% below its estimated fair value. The current Days Payable is 131.71, which is 41% above median its 10-year median of 93.28 and 19.7% above the Biotechnology industry median of 110.01. Inner Mongolia Furui Medical Science Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Inner Mongolia Furui Medical Science Co (SZSE:300049), the current Days Payable is 131.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inner Mongolia Furui Medical Science Co (SZSE:300049) Overvalued in 2026?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co stock appears to be undervalued.
The current stock price of ¥43.94 is trading 33.4% below its estimated GF Value™ of ¥65.97.
GuruFocus considers Inner Mongolia Furui Medical Science Co to be Significantly Undervalued.
Key valuation signals for SZSE:300049:
Days Payable: 131.71 (41% above median its 10-year median of 93.28)
GF Value™: ¥65.97 vs. price of ¥43.94 (33.4% below fair value)
Industry Position: 19.7% above the Biotechnology median (#365 of 704)
No single metric tells the full story. See the SZSE:300049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
81GF Score
Get the complete analysis for SZSE:300049
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300049 has been successfully added to your 
